[EN] ATX MODULATING AGENTS<br/>[FR] AGENTS DE MODULATION D'ATX
申请人:BIOGEN MA INC
公开号:WO2015188051A1
公开(公告)日:2015-12-10
Compounds of formula (I) can modulate the activity of autotaxin (ATX).
式(I)的化合物可以调节自体税肽酶(ATX)的活性。
[EN] SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS<br/>[FR] SYNTHÈSE DE LACTONES D'ACIDE RÉSORCYLIQUE UTILES EN TANT QU'AGENTS THÉRAPEUTIQUES
申请人:UNIV STRASBOURG
公开号:WO2009091921A1
公开(公告)日:2009-07-23
Disclosed are macrocyclic compounds of formulae I, I', II, II', III, III', IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.
[EN] S1P MODULATING AGENTS<br/>[FR] AGENTS MODULATEURS DE S1P
申请人:BIOGEN IDEC INC
公开号:WO2014120764A1
公开(公告)日:2014-08-07
Compounds of formula (I) can modulate the activity of one or more S 1P receptors. Sphingosine 1-phosphate (S IP) is a lysophospholipid mediator that evokes a variety of cellular responses by stimulation of five members of the endothelial cell differentiation gene (EDG) receptor family, namely S1P1, S1P2, S1P3, S1P4, and S1P5 (formerly EDG1, EDG5, EDG3, EDG6 and EDG8). The EDG receptors are G-protein coupled receptors (GPCRs) and on stimulation propagate second messenger signals via activation of heterotrimeric G-protein alpha (Ga.) subunits and beta-gamma (G()y) dimers.
1,3-Bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
申请人:——
公开号:US20030232877A1
公开(公告)日:2003-12-18
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
1
or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.